Skip to main content

Table 2 Baseline characteristics of AIS patients with IDDVT and Non-IDDVT in training cohort

From: Individualized predictions of early isolated distal deep vein thrombosis in patients with acute ischemic stroke: a retrospective study

Variables Training cohort (n = 431)
Non-IDDVT (n = 335) IDDVT (n = 96) P-value
Demographic characteristics
Age (years) 67.6 ± 12.6 73.4 ± 8.4 < 0.001
Gender    0.001
male, n (%) 212 (63.3%) 43 (44.8%)  
female, n (%) 123 (36.7%) 53 (55.2%)  
Subtype of stroke, n (%)    0.248
Large-artery atherosclerosis 271 (80.9%) 69 (71.9%)  
Cardioembolism 36 (10.7%) 18 (18.8%)  
Small-artery occlusion 2 (0.6%) 0  
Other or undetermined 15 (4.5%) 5 (5.2%)  
Unknown 11 (3.3%) 4 (4.2%)  
Clinical parameters, n (%)
Lower limb paralysis 112 (33.4%) 57 (59.4%) < 0.001
Current pneumonia 49 (14.6%) 35 (36.5%) < 0.001
Atrial fibrillation 48 (14.3%) 33 (34.4%) < 0.001
Arterial hypertension 256 (76.4%) 71 (74.0%) 0.620
Diabetes mellitus 115 (34.3%) 36 (37.5%) 0.566
Current malignant tumor 11 (3.3%) 10 (10.4%) 0.004
Current uarthritis 15 (4.5%) 2 (2.1%) 0.288
Laboratory parameters
Albumin (g/L) 37.1 ± 4.2 36.4 ± 4.0 0.170
Fast blood glucose (mmol/L) 5.9 ± 2.2 6.0 ± 2.4 0.556
SCr (μmol/L) 68.0 (57.0–83.0) 63.5 (52.0–78.2) 0.016
Hcy (μmol/L) 6.1 ± 3.8 6.3 ± 3.9 0.697
INR 1.1 ± 0.3 1.1 ± 0.2 0.673
Fibrinogen (g/L) 3.6 ± 1.5 3.6 ± 1.6 0.848
D-Dimer (mg/L) 1.2 (0.8–2.1) 1.8 (1.2–3.7) < 0.001
CRP (mg/L) 7.3 (3.2–18.6) 14.6 (5.9–31.5) 0.008
hs-CRP (mg/L) 3.5 (1.0–11.8) 8.5 (3.9–32.4) 0.021
1 n (%)
Anticoagulants 101 (30.1%) 37 (38.5%) 0.120
Antiplatelet 281 (83.9%) 77 (80.2%) 0.398
Lipid-lowering agents 324 (96.7%) 93 (96.9%) 0.938
Thrombolysis treatment 12 (3.6%) 8 (8.3%) 0.051
  1. NOTE. CRP c-reactive protein; Hcy homocysteine; hs-CRP high-sensitivity C-reactive protein; IDDVT isolated distal deep venous thrombosis; SCr serum creatinine concentration